VGX™ Pharmaceuticals

	7/7/2008 Inovio Biomedical and VGX Pharmaceuticals Sign Merger Agreement
	7/7/2008 VGX Pharmaceuticals announces the discontinuation of its PICTOVIR™ Program
	7/1/2008 VGX Pharmaceuticals receives FDA approval of IND for novel DNA vaccine for cervical cancer therapy

	August 13-15, 2008 Cambridge, MA, USA Novel vaccines: bridging research development and production
	July 17-18, 2008 National Harbor, MD, USA IBC: Next Generation Vaccines: Production Technologies & Advances